| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_129e393582e6bdf4029baf2206522f45 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-048 |
| filingDate |
2015-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e98bd607966cb9cb0886f8d851a939af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_242e79ff2bb79a04a003e29bec3a240b |
| publicationDate |
2017-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2017100953-A |
| titleOfInvention |
Tetrahydrobenzoflozepine derivatives and their pharmaceutical use |
| abstract |
Disclosed is a therapeutic or prophylactic agent for stress urinary incontinence having 5-HT2C receptor agonist activity. The present invention provides a tetrahydrobenzoflozepine derivative represented by the following or a pharmacologically acceptable acid addition salt thereof. [Selection figure] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019131902-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023114858-A1 |
| priorityDate |
2015-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |